InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
12
T+90 hit rate
0%
T+90 mean return
-82.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Christianson Mark, Directeur du Développement Commercial. Director active across 1 company, notably NEUROONE MEDICAL TECHNOLOGIES Corp. In total, 44 filings have been published. Split: 0 buy · 12 sells. Total volume traded: €309k. History available since 23 June 2021. The latest transaction was filed on 21 May 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations44 total
14 shares@ US$0.650.0% of flowCommon StockSEC:0001709738-25-000006:0
▼
8,006 shares@ US$0.66571.5% of flowCommon StockSEC:0001709738-25-000005:0
●
253 shares@ US$0.85020.1% of flowCommon StockSEC:0001709738-25-000003:0
●
1,812 shares@ US$1.160.6% of flowCommon StockSEC:0001709738-25-000002:0
●
90 shares@ US$1.150.0% of flowCommon StockSEC:0001709738-25-000001:0
●
343 shares@ US$0.8260.1% of flowCommon StockSEC:0001213900-25-000717:0
●
90 shares@ US$0.62310.0% of flowCommon StockSEC:0001709738-24-000015:0
●
90 shares@ US$0.970.0% of flowCommon StockSEC:0001709738-24-000014:0
●
343 shares@ US$0.990.1% of flowCommon StockSEC:0001709738-24-000013:0
●
90 shares@ US$0.79640.0% of flowCommon StockSEC:0001709738-24-000012:0
●
90 shares@ US$0.750.0% of flowCommon StockSEC:0001709738-24-000011:0
●
343 shares@ US$0.800.1% of flowCommon StockSEC:0001709738-24-000010:0
▼
2,189 shares@ US$0.8760.6% of flowCommon StockSEC:0001709738-24-000009:0
▼
25,800 shares@ US$0.87846.5% of flowCommon StockSEC:0001709738-24-000008:0
●
90 shares@ US$0.92990.0% of flowCommon StockSEC:0001709738-24-000007:0
●
90 shares@ US$1.130.0% of flowCommon StockSEC:0001709738-24-000006:0
●
2,030 shares@ US$1.150.7% of flowCommon StockSEC:0001709738-24-000005:0
●
90 shares@ US$1.200.0% of flowCommon StockSEC:0001709738-24-000004:0
●
90 shares@ US$1.210.0% of flowCommon StockSEC:0001709738-24-000003:0
25,000 shares0Common StockSEC:0001709738-24-000002:0
●
90 shares@ US$1.250.0% of flowCommon StockSEC:0001709738-24-000001:0
●
90 shares@ US$1.580.0% of flowCommon StockSEC:0001213900-24-000531:0
▼
6,848 shares@ US$1.35362.6% of flowCommon StockSEC:0001709738-23-000016:0
▼
9,907 shares@ US$1.404.0% of flowCommon StockSEC:0001709738-23-000015:0
▼
1,800 shares@ US$1.400.7% of flowCommon StockSEC:0001709738-23-000015:1
25 of 44 declarations
About Christianson Mark
Christianson Mark is the Business Development Director at NEUROONE MEDICAL TECHNOLOGIES Corp. In this role, he is responsible for business expansion and creating new commercial opportunities. His expertise is essential for the strategic development of the company.
